IMGN logo

ImmunoGen (IMGN) Net Income

Annual Net Income

-$222.93 M
-$83.63 M-60.03%

December 31, 2022

Summary

Performance

1-Year Change

-60.03%

3-Year Change

-114.08%

5-Year Change

-132.19%

15-Year Change

-132.19%

IMGN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$237.60 K

3-Year Low

-$222.93 M
IMGN annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNprofitabilitymetrics:

Annual Net Margin

-204.93%
IMGN annual net profit margin is -204.93%

Annual Revenue

$108.78 M
IMGN annual revenue is $108.78 million

Annual Gross Profit

$108.61 M
IMGN annual gross profit is $108.61 million

Annual EPS

-$0.88
IMGN annual earnings per share is -$0.88

Quarterly Net Income

$30.75 M
+$35.00 M+823.82%

September 30, 2023

Summary

Performance

3-Month Change

+823.82%

1-Year Change

+139.54%

3-Year Change

+237.43%

5-Year Change

+165.69%

IMGN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$31.39 M
IMGN quarterly net profit is currently -2.04% below its historical high of $31.39 million

3-Year Low

-$77.75 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNprofitabilitymetrics:

Quarterly Net Margin

27.11%
IMGN quarterly net profit margin is 27.11%

Quarterly Revenue

$113.42 M
IMGN quarterly revenue is $113.42 million

Quarterly Gross Profit

$111.27 M
IMGN quarterly gross profit is $111.27 million

Quarterly EPS

$0.10
IMGN quarterly earnings per share is $0.10

TTM Net Income

-$73.52 M
+$108.50 M+59.61%

September 30, 2023

Summary

Performance

3-Month Change

+59.61%

1-Year Change

+63.44%

3-Year Change

-3.63%

5-Year Change

+29.4%

IMGN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$900.00 K
IMGN TTM net profit is currently -8269.11% below its historical high of $900.00 thousand

3-Year Low

-$239.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNprofitabilitymetrics:

Annual Net Margin

-204.93%
IMGN annual net profit margin is -204.93%

TTM Revenue

$287.61 M
IMGN TTM revenue is $287.61 million

TTM Gross Profit

$283.75 M
IMGN TTM gross profit is $283.75 million

TTM EPS

-$0.31
IMGN TTM earnings per share is -$0.31

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$222.93 M
IMGN annual net profit is -$222.93 million

Annual Revenue

$108.78 M
IMGN annual revenue is $108.78 million

Annual Cost Of Goods Sold

$176.00 K
IMGN annual cost of goods sold is $176.00 thousand

Annual Operating Expenses

$329.50 M
IMGN annual total operating expenses is $329.50 million

Annual Interest Expense

$4.17 M
IMGN annual interest expense is $4.17 million

Annual Income Tax

$1.22 M
IMGN annual income tax is $1.22 million

IMGN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-60.0%+139.5%+63.4%
3 y3 years-114.1%+237.4%-3.6%
5 y5 years-132.2%+165.7%+29.4%

IMGN Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+60.0%at lowat high-352.9%at high+226.2%
5 y5-year+402.4%at low-2.0%-352.9%+65.7%+226.2%
alltimeall time>+9999.0%at low-2.0%-352.9%-8269.1%+226.2%

ImmunoGen Net Income History

DateAnnualQuarterlyTTM
Sep 2023
-
$30.75 M(-823.8%)
-$73.52 M(-59.6%)
Jun 2023
-
-$4.25 M(-89.6%)
-$182.03 M(-24.1%)
Mar 2023
-
-$41.01 M(-30.5%)
-$239.80 M(+7.6%)
Dec 2022
-$222.93 M(+60.0%)
-$59.01 M(-24.1%)
-$222.93 M(+10.9%)
Sep 2022
-
-$77.75 M(+25.4%)
-$201.09 M(+25.2%)
Jun 2022
-
-$62.02 M(+156.9%)
-$160.68 M(+24.2%)
Mar 2022
-
-$24.14 M(-35.0%)
-$129.40 M(-7.1%)
Dec 2021
-$139.30 M(+213.9%)
-$37.17 M(-0.4%)
-$139.30 M(+96.9%)
Sep 2021
-
-$37.34 M(+21.5%)
-$70.74 M(+26.8%)
Jun 2021
-
-$30.74 M(-9.7%)
-$55.78 M(+13.1%)
Mar 2021
-
-$34.05 M(-208.5%)
-$49.34 M(+11.2%)
Dec 2020
-$44.37 M(-57.4%)
$31.39 M(-240.3%)
-$44.37 M(-37.5%)
Sep 2020
-
-$22.37 M(-7.9%)
-$70.95 M(+0.9%)
Jun 2020
-
-$24.30 M(-16.5%)
-$70.32 M(-21.4%)
Mar 2020
-
-$29.09 M(-704.2%)
-$89.47 M(-14.1%)
Dec 2019
-$104.13 M(-38.3%)
$4.81 M(-122.1%)
-$104.13 M(-30.9%)
Sep 2019
-
-$21.75 M(-49.9%)
-$150.75 M(-14.3%)
Jun 2019
-
-$43.45 M(-0.7%)
-$175.80 M(+1.0%)
Mar 2019
-
-$43.75 M(+4.7%)
-$173.98 M(+3.0%)
Dec 2018
-$168.84 M(+75.9%)
-$41.80 M(-10.7%)
-$168.84 M(+20.5%)
Sep 2018
-
-$46.81 M(+12.5%)
-$140.16 M(-6.6%)
Jun 2018
-
-$41.62 M(+7.8%)
-$150.04 M(+27.9%)
Mar 2018
-
-$38.61 M(+194.4%)
-$117.28 M(+22.2%)
Dec 2017
-$96.01 M(+21.7%)
-$13.12 M(-76.9%)
-$96.01 M(+15.8%)
Sep 2017
-
-$56.68 M(+539.2%)
-$82.89 M(+16.8%)
Jun 2017
-
-$8.87 M(-48.9%)
-$70.94 M(-34.3%)
Mar 2017
-
-$17.34 M(-61.2%)
-$108.00 M(-30.7%)
Dec 2016
-$78.88 M(-45.5%)
-
-
Sep 2016
-
-$44.73 M(-2.6%)
-$155.81 M(+7.6%)
Jun 2016
-$144.82 M(+138.4%)
-$45.92 M(+43.8%)
-$144.82 M(+11.9%)
Mar 2016
-
-$31.93 M(-3.9%)
-$129.37 M(+8.7%)
Dec 2015
-
-$33.23 M(-1.5%)
-$119.06 M(+64.9%)
Sep 2015
-
-$33.74 M(+10.7%)
-$72.20 M(+18.9%)
Jun 2015
-$60.74 M(-14.9%)
-$30.47 M(+41.0%)
-$60.74 M(+7.0%)
Mar 2015
-
-$21.62 M(-258.5%)
-$56.76 M(-21.8%)
Dec 2014
-
$13.63 M(-161.2%)
-$72.60 M(-11.9%)
Sep 2014
-
-$22.28 M(-15.9%)
-$82.42 M(+15.5%)
Jun 2014
-$71.36 M(-2.0%)
-$26.50 M(-29.2%)
-$71.36 M(+6.9%)
Mar 2014
-
-$37.45 M(-1082.2%)
-$66.74 M(+117.8%)
Dec 2013
-
$3.81 M(-134.0%)
-$30.64 M(-47.9%)
Sep 2013
-
-$11.23 M(-48.7%)
-$58.84 M(-19.2%)
Jun 2013
-$72.81 M(-0.7%)
-$21.88 M(+1519.2%)
-$72.81 M(-0.7%)
Mar 2013
-
-$1.35 M(-94.5%)
-$73.35 M(-19.1%)
Dec 2012
-
-$24.39 M(-3.2%)
-$90.67 M(+14.7%)
Sep 2012
-
-$25.19 M(+12.4%)
-$79.03 M(+7.8%)
Jun 2012
-$73.32 M(+25.8%)
-$22.41 M(+20.1%)
-$73.32 M(+9.3%)
Mar 2012
-
-$18.67 M(+46.4%)
-$67.06 M(+5.8%)
Dec 2011
-
-$12.75 M(-34.5%)
-$63.39 M(-2.3%)
Sep 2011
-
-$19.48 M(+20.6%)
-$64.87 M(+11.3%)
Jun 2011
-$58.27 M(+14.5%)
-$16.15 M(+7.6%)
-$58.27 M(+4.9%)
Mar 2011
-
-$15.00 M(+5.4%)
-$55.53 M(+5.5%)
Dec 2010
-
-$14.23 M(+10.4%)
-$52.65 M(+2.4%)
Sep 2010
-
-$12.89 M(-3.9%)
-$51.42 M(+1.0%)
Jun 2010
-$50.91 M(+59.4%)
-$13.40 M(+10.6%)
-$50.91 M(+5.3%)
Mar 2010
-
-$12.12 M(-6.8%)
-$48.33 M(+18.4%)
Dec 2009
-
-$13.01 M(+5.1%)
-$40.82 M(+16.9%)
Sep 2009
-
-$12.38 M(+14.3%)
-$34.91 M(+9.3%)
Jun 2009
-$31.94 M(-0.3%)
-$10.83 M(+134.9%)
-$31.94 M(-3.3%)
Mar 2009
-
-$4.61 M(-35.1%)
-$33.04 M(-20.0%)
Dec 2008
-
-$7.10 M(-24.4%)
-$41.28 M(+2.2%)
Sep 2008
-
-$9.40 M(-21.2%)
-$40.38 M(+26.1%)
Jun 2008
-$32.02 M(+68.6%)
-$11.93 M(-7.2%)
-$32.02 M(+30.1%)
Mar 2008
-
-$12.85 M(+106.8%)
-$24.62 M(+45.4%)
Dec 2007
-
-$6.21 M(+501.9%)
-$16.93 M(+23.0%)
Sep 2007
-
-$1.03 M(-77.2%)
-$13.77 M(-27.5%)
Jun 2007
-$18.99 M(+6.5%)
-$4.53 M(-12.2%)
-$18.99 M(-10.0%)
Mar 2007
-
-$5.16 M(+69.5%)
-$21.10 M(+11.5%)
Dec 2006
-
-$3.04 M(-51.3%)
-$18.92 M(-2.4%)
Sep 2006
-
-$6.25 M(-5.9%)
-$19.38 M(+8.7%)
Jun 2006
-$17.83 M
-$6.64 M(+122.9%)
-$17.83 M(+28.2%)
DateAnnualQuarterlyTTM
Mar 2006
-
-$2.98 M(-14.9%)
-$13.91 M(-3.9%)
Dec 2005
-
-$3.50 M(-25.6%)
-$14.48 M(+9.8%)
Sep 2005
-
-$4.71 M(+73.0%)
-$13.19 M(+20.4%)
Jun 2005
-$10.95 M(+85.1%)
-$2.72 M(-23.4%)
-$10.95 M(+38.1%)
Mar 2005
-
-$3.55 M(+60.8%)
-$7.93 M(+54.3%)
Dec 2004
-
-$2.21 M(-10.6%)
-$5.14 M(+20.6%)
Sep 2004
-
-$2.47 M(-918.2%)
-$4.26 M(-28.0%)
Jun 2004
-$5.92 M(-70.4%)
$302.00 K(-139.7%)
-$5.92 M(-54.8%)
Mar 2004
-
-$760.00 K(-43.0%)
-$13.08 M(-22.8%)
Dec 2003
-
-$1.33 M(-67.7%)
-$16.93 M(-18.9%)
Sep 2003
-
-$4.13 M(-39.8%)
-$20.89 M(+4.5%)
Jun 2003
-$19.98 M(+36.6%)
-$6.86 M(+48.6%)
-$19.98 M(+13.8%)
Mar 2003
-
-$4.62 M(-12.6%)
-$17.56 M(-11.4%)
Dec 2002
-
-$5.29 M(+64.1%)
-$19.81 M(+21.9%)
Sep 2002
-
-$3.22 M(-27.3%)
-$16.26 M(+11.1%)
Jun 2002
-$14.63 M(-4.3%)
-$4.43 M(-35.5%)
-$14.63 M(+8.6%)
Mar 2002
-
-$6.87 M(+296.7%)
-$13.47 M(+60.7%)
Dec 2001
-
-$1.73 M(+8.8%)
-$8.39 M(-8.5%)
Sep 2001
-
-$1.59 M(-51.4%)
-$9.17 M(-40.0%)
Jun 2001
-$15.29 M(+6335.5%)
-$3.28 M(+83.6%)
-$15.29 M(+35.3%)
Mar 2001
-
-$1.79 M(-29.0%)
-$11.30 M(-8.3%)
Dec 2000
-
-$2.52 M(-67.4%)
-$12.32 M(+26.9%)
Sep 2000
-
-$7.71 M(-1184.1%)
-$9.71 M(+4931.6%)
Jun 2000
-$237.60 K(-94.2%)
$711.50 K(-125.4%)
-$192.90 K(-84.0%)
Mar 2000
-
-$2.80 M(-2904.4%)
-$1.20 M(-233.8%)
Dec 1999
-
$100.00 K(-94.4%)
$900.00 K(-212.5%)
Sep 1999
-
$1.80 M(-700.0%)
-$800.00 K(-80.5%)
Jun 1999
-$4.10 M(-46.1%)
-$300.00 K(-57.1%)
-$4.10 M(-34.9%)
Mar 1999
-
-$700.00 K(-56.3%)
-$6.30 M(-11.3%)
Dec 1998
-
-$1.60 M(+6.7%)
-$7.10 M(-2.7%)
Sep 1998
-
-$1.50 M(-40.0%)
-$7.30 M(-3.9%)
Jun 1998
-$7.60 M(-15.6%)
-$2.50 M(+66.7%)
-$7.60 M(+8.6%)
Mar 1998
-
-$1.50 M(-16.7%)
-$7.00 M(-10.3%)
Dec 1997
-
-$1.80 M(0.0%)
-$7.80 M(-8.2%)
Sep 1997
-
-$1.80 M(-5.3%)
-$8.50 M(-5.6%)
Jun 1997
-$9.00 M(-45.5%)
-$1.90 M(-17.4%)
-$9.00 M(-26.8%)
Mar 1997
-
-$2.30 M(-8.0%)
-$12.30 M(-3.1%)
Dec 1996
-
-$2.50 M(+8.7%)
-$12.70 M(-16.4%)
Sep 1996
-
-$2.30 M(-55.8%)
-$15.20 M(-7.9%)
Jun 1996
-$16.50 M(-17.1%)
-$5.20 M(+92.6%)
-$16.50 M(+7.8%)
Mar 1996
-
-$2.70 M(-46.0%)
-$15.30 M(-9.5%)
Dec 1995
-
-$5.00 M(+38.9%)
-$16.90 M(-6.1%)
Sep 1995
-
-$3.60 M(-10.0%)
-$18.00 M(-9.5%)
Jun 1995
-$19.90 M(-16.0%)
-$4.00 M(-7.0%)
-$19.90 M(-11.6%)
Mar 1995
-
-$4.30 M(-29.5%)
-$22.50 M(-7.4%)
Dec 1994
-
-$6.10 M(+10.9%)
-$24.30 M(-0.4%)
Sep 1994
-
-$5.50 M(-16.7%)
-$24.40 M(+2.5%)
Jun 1994
-$23.70 M(+27.4%)
-$6.60 M(+8.2%)
-$23.80 M(+6.3%)
Mar 1994
-
-$6.10 M(-1.6%)
-$22.40 M(+7.2%)
Dec 1993
-
-$6.20 M(+26.5%)
-$20.90 M(+6.1%)
Sep 1993
-
-$4.90 M(-5.8%)
-$19.70 M(+5.9%)
Jun 1993
-$18.60 M(+21.6%)
-$5.20 M(+13.0%)
-$18.60 M(+5.7%)
Mar 1993
-
-$4.60 M(-8.0%)
-$17.60 M(+2.3%)
Dec 1992
-
-$5.00 M(+31.6%)
-$17.20 M(+12.4%)
Sep 1992
-
-$3.80 M(-9.5%)
-$15.30 M(0.0%)
Jun 1992
-$15.30 M(+73.9%)
-$4.20 M(0.0%)
-$15.30 M(+9.3%)
Mar 1992
-
-$4.20 M(+35.5%)
-$14.00 M(+10.2%)
Dec 1991
-
-$3.10 M(-18.4%)
-$12.70 M(+2.4%)
Sep 1991
-
-$3.80 M(+31.0%)
-$12.40 M(+40.9%)
Jun 1991
-$8.80 M(+6.0%)
-$2.90 M(0.0%)
-$8.80 M(+4.8%)
Mar 1991
-
-$2.90 M(+3.6%)
-$8.40 M(+10.5%)
Dec 1990
-
-$2.80 M(+1300.0%)
-$7.60 M(+10.1%)
Sep 1990
-
-$200.00 K(-92.0%)
-$6.90 M(-16.9%)
Jun 1990
-$8.30 M(+56.6%)
-$2.50 M(+19.0%)
-$8.30 M(+13.7%)
Mar 1990
-
-$2.10 M(0.0%)
-$7.30 M(+10.6%)
Dec 1989
-
-$2.10 M(+31.3%)
-$6.60 M(+11.9%)
Sep 1989
-
-$1.60 M(+6.7%)
-$5.90 M(+11.3%)
Jun 1989
-$5.30 M
-$1.50 M(+7.1%)
-$5.30 M(+39.5%)
Mar 1989
-
-$1.40 M(0.0%)
-$3.80 M(+58.3%)
Dec 1988
-
-$1.40 M(+40.0%)
-$2.40 M(+140.0%)
Sep 1988
-
-$1.00 M
-$1.00 M

FAQ

  • What is ImmunoGen annual net profit?
  • What is the all time high annual net income for ImmunoGen?
  • What is ImmunoGen annual net income year-on-year change?
  • What is ImmunoGen quarterly net profit?
  • What is the all time high quarterly net income for ImmunoGen?
  • What is ImmunoGen quarterly net income year-on-year change?
  • What is ImmunoGen TTM net profit?
  • What is the all time high TTM net income for ImmunoGen?
  • What is ImmunoGen TTM net income year-on-year change?

What is ImmunoGen annual net profit?

The current annual net income of IMGN is -$222.93 M

What is the all time high annual net income for ImmunoGen?

ImmunoGen all-time high annual net profit is -$237.60 K

What is ImmunoGen annual net income year-on-year change?

Over the past year, IMGN annual net profit has changed by -$83.63 M (-60.03%)

What is ImmunoGen quarterly net profit?

The current quarterly net income of IMGN is $30.75 M

What is the all time high quarterly net income for ImmunoGen?

ImmunoGen all-time high quarterly net profit is $31.39 M

What is ImmunoGen quarterly net income year-on-year change?

Over the past year, IMGN quarterly net profit has changed by +$108.50 M (+139.54%)

What is ImmunoGen TTM net profit?

The current TTM net income of IMGN is -$73.52 M

What is the all time high TTM net income for ImmunoGen?

ImmunoGen all-time high TTM net profit is $900.00 K

What is ImmunoGen TTM net income year-on-year change?

Over the past year, IMGN TTM net profit has changed by +$127.57 M (+63.44%)